Key result
Specific combinations of actin and smooth muscle tropomyosin isoforms significantly alter actin-myosin interaction kinetics, such as a 1.12-fold increase in sliding velocity for alpha-actin with tropomyosin-ab.
Specific combinations of actin and smooth muscle tropomyosin isoforms exert distinct regulatory effects on smooth muscle actin-myosin interaction kinetics in vitro.
Answers are grounded in this paper and cite their sources.
Requires in vivo validation before any clinical consideration; leaves open isoform roles in human smooth muscle disorders.
The proteins involved in smooth muscle's molecular contractile mechanism - the anti-parallel motion of actin and myosin filaments driven by myosin heads interacting with actin - are found as different isoforms. While their expression levels are altered in disease states, their relevance to the mechanical interaction of myosin with actin is not sufficiently understood. Here, we analyzed in vitro actin filament propulsion by smooth muscle myosin for [Formula: see text]-actin ([Formula: see text]A), [Formula: see text]-actin-tropomyosin-[Formula: see text] ([Formula: see text]A-Tm[Formula: see text]), [Formula: see text]-actin-tropomyosin-[Formula: see text] ([Formula: see text]A-Tm[Formula: see text]), [Formula: see text]-actin ([Formula: see text]A), [Formula: see text]-actin-tropomyosin-[Formula: see text] ([Formula: see text]A-Tm[Formula: see text]), and [Formula: see text]-actin-tropomoysin-[Formula: see text] ([Formula: see text]A-Tm[Formula: see text]). Actin sliding analysis with our specifically developed video analysis software followed by statistical assessment (Bootstrapped Principal Component Analysis) indicated that the in vitro motility of [Formula: see text]A, [Formula: see text]A, and [Formula: see text]A-Tm[Formula: see text] is not distinguishable. Compared to these three 'baseline conditions', statistically significant differences ([Formula: see text]) were: [Formula: see text]A-Tm[Formula: see text] - actin sliding velocity increased 1.12-fold, [Formula: see text]A-Tm[Formula: see text] - motile fraction decreased to 0.96-fold, stop time elevated 1.6-fold, [Formula: see text]A-Tm[Formula: see text] - run time elevated 1.7-fold. We constructed a mathematical model, simulated actin sliding data, and adjusted the kinetic parameters so as to mimic the experimentally observed differences: [Formula: see text]A-Tm[Formula: see text] - myosin binding to actin, the main, and the secondary myosin power stroke are accelerated, [Formula: see text]A-Tm[Formula: see text] - mechanical coupling between myosins is stronger, [Formula: see text]A-Tm[Formula: see text] - the secondary power stroke is decelerated and mechanical coupling between myosins is weaker. In summary, our results explain the different regulatory effects that specific combinations of actin and smooth muscle tropomyosin have on smooth muscle actin-myosin interaction kinetics.
No takes yet. Share an insight, caveat, or question.
Hilbert et al. (2013) studied this question. Smooth muscle tropomyosin isoforms vs. Baseline conditions without tropomyosin or with different isoforms was evaluated on In vitro actin sliding velocity and motility features (p=<0.05). Specific combinations of actin and smooth muscle tropomyosin isoforms significantly alter actin-myosin interaction kinetics, such as a 1.12-fold increase in sliding velocity for alpha-actin with tropomyosin-ab.
Synapse has enriched 10 related papers. Consider them for comparative context: